Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Thalassaemia Society Pakistan, Lahore, Pakistan.
Eur J Hum Genet. 2022 Apr;30(4):406-412. doi: 10.1038/s41431-021-00974-y. Epub 2021 Oct 4.
Low uptake of cascade screening for βeta-thalassaemia major (β-TM) in the 'Punjab Thalassaemia Prevention Project' (PTPP) in Pakistan led to the development of a 'decision support intervention for relatives' (DeSIRe). This paper presents the experiences of relatives of children with β-TM of the DeSIRe following its use by PTPP field officers (FOs) in routine clinical practice. Fifty-four semi-structured qualitative interviews were conducted (April to June 2021) with relatives in seven cities in the Punjab province (Lahore, Sheikhupura, Nankana Sahab, Kasur, Gujranwala, Multan and Faisalabad). Thematic analysis shows that participants were satisfied with the content of the DeSIRe and its delivery by the FOs in a family meeting. They understood that the main purpose of the DeSIRe was to improve their knowledge of β-TM and its inheritance, and to enable them to make decisions about thalassaemia carrier testing, particularly before marriage. Participants also raised concerns about the stigma of testing positive; however, they believed the DeSIRe was an appropriate intervention, which supported relatives to make informed decisions. Our findings show that the DeSIRe is appropriate for use by healthcare professionals in routine practice in a low-middle income country, and has the potential to facilitate shared decision making about cascade screening for thalassaemia. Further research is needed to prove the efficacy of the DeSIRe.
巴基斯坦“旁遮普省地中海贫血症预防项目”(PTPP)中β-地中海贫血症(β-TM)级联筛查的参与率较低,因此开发了一种“亲属决策支持干预(DeSIRe)”。本文介绍了在 PTPP 现场工作人员在常规临床实践中使用 DeSIRe 后,β-TM 患儿亲属的使用经验。2021 年 4 月至 6 月,在旁遮普省的七个城市(拉合尔、谢赫布巴扎尔、南克纳萨布、卡苏尔、古杰兰瓦拉、木尔坦和费萨拉巴德)对 54 名亲属进行了 54 次半结构化定性访谈。主题分析表明,参与者对 DeSIRe 的内容及其在家庭会议中由现场工作人员提供的方式感到满意。他们理解 DeSIRe 的主要目的是提高他们对β-TM 及其遗传的认识,并使他们能够做出关于地中海贫血携带者检测的决定,特别是在结婚前。参与者还对检测呈阳性的耻辱感表示担忧;然而,他们认为 DeSIRe 是一种适当的干预措施,支持亲属做出明智的决定。我们的研究结果表明,DeSIRe 适合中低收入国家的医疗保健专业人员在常规实践中使用,并有潜力促进有关地中海贫血症级联筛查的共同决策。需要进一步研究来证明 DeSIRe 的疗效。